<qa>  What is the name of the patient with non-melanoma skin cancer or carcinoma in- Diagnosed or treated for another malignancy within 2 years before study enrollment or previously diagnosed 2 years before study enrollment with another malignancy and have any evidence of residual disease that is symptomatic or requiring treatment; patients with non-melanoma skin cancer or carcinoma in situ of any type are not excluded if they have undergone complete resection 